At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ODD ODDITY Tech Ltd.
Trading 09-29 12:30:57 EDT
17.56
-0.04
-0.23%
High17.96Low17.36Vol209.92K
Open17.79D1 Closing17.60Amplitude3.38%
Mkt Cap809.95MTradable Cap501.97MTotal Shares46.12M
T/O3.70MT/O Rate0.73%Tradable Shares28.59M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
GlobeNewswire  ·  09-29 19:05
Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for Relapsed/Refractory AL Amyloidosis
GlobeNewswire  ·  09-29 19:00
Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for Relapsed/Refractory AL Amyloidosis
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition
GlobeNewswire  ·  09-28 14:49
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition
Court Grants Motion to Dismiss Oddity Tech (ODD) Securities Lawsuit, Finding Material Misstatements Were Not Adequately Pleaded
TIPRANKS  ·  09-24
Court Grants Motion to Dismiss Oddity Tech (ODD) Securities Lawsuit, Finding Material Misstatements Were Not Adequately Pleaded
Goldman Sachs Sticks to Its Sell Rating for ODDITY Tech Ltd. Class A (ODD)
TIPRANKS  ·  09-14
Goldman Sachs Sticks to Its Sell Rating for ODDITY Tech Ltd. Class A (ODD)
WCLC 2026 | Leads Biolabs’ Opamtistomig (LBL-024) Oral Presentation Demonstrates Robust Response and PFS Benefits in First‑Line NSCLC
GlobeNewswire  ·  09-14
WCLC 2026 | Leads Biolabs’ Opamtistomig (LBL-024) Oral Presentation Demonstrates Robust Response and PFS Benefits in First‑Line NSCLC
ODDITY Tech Earnings Call: Growth Brands vs Ad Shock
TIPRANKS  ·  09-12
ODDITY Tech Earnings Call: Growth Brands vs Ad Shock
Oddity Tech Price Target Raised to $18.00/Share from $16.00 by Jefferies
Dow Jones  ·  09-10
Oddity Tech Price Target Raised to $18.00/Share from $16.00 by Jefferies
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Delfi (OtherPEFDF) and ODDITY Tech Ltd. Class A (ODD)
TIPRANKS  ·  09-10
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Delfi (OtherPEFDF) and ODDITY Tech Ltd. Class A (ODD)
Oddity Tech Surges to More than 7-Month High After Earnings, Outlook
Reuters  ·  09-10
Oddity Tech Surges to More than 7-Month High After Earnings, Outlook
Oddity price target raised to $18 from $16 at Jefferies
TIPRANKS  ·  09-10
Oddity price target raised to $18 from $16 at Jefferies
Short Squeeze And Earnings: Why ODDITY Tech Stock Spiked Wednesday
Benzinga Earnings  ·  09-10
Short Squeeze And Earnings: Why ODDITY Tech Stock Spiked Wednesday
Oddity Tech Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  09-09
Oddity Tech Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary
Oddity Tech Shares Rise on 2Q Beat, Rosier 3Q Outlook
Dow Jones  ·  09-09
Oddity Tech Shares Rise on 2Q Beat, Rosier 3Q Outlook
Oddity Tech Shares up 32.8% to $17.18 Premarket After Q2 Results Beat
THOMSON REUTERS  ·  09-09
Oddity Tech Shares up 32.8% to $17.18 Premarket After Q2 Results Beat
Oddity Tech Q2 Adjusted Earnings, Revenue Fall; Issues Revenue Guidance
MT Newswires Live  ·  09-09
Oddity Tech Q2 Adjusted Earnings, Revenue Fall; Issues Revenue Guidance
ODDITY Q2 2026 Earnings: Revenue Falls 25% amid IL MAKIAGE Dislocation
TradingKey  ·  09-09
ODDITY Q2 2026 Earnings: Revenue Falls 25% amid IL MAKIAGE Dislocation
Il Makiage Parent Oddity Tech's Q2 Profit Beats on SpoiledChild Brand Growth
Reuters  ·  09-09
Il Makiage Parent Oddity Tech's Q2 Profit Beats on SpoiledChild Brand Growth
Oddity Tech Q2 Adjusted EPS USD 0.2 Vs. IBES Estimate USD 0.16
Reuters  ·  09-09
Oddity Tech Q2 Adjusted EPS USD 0.2 Vs. IBES Estimate USD 0.16
Earnings Flash (ODD) Oddity Tech Posts Q2 Adjusted EPS $0.20, vs. FactSet Est of $0.12
MT Newswires Live  ·  09-09
Earnings Flash (ODD) Oddity Tech Posts Q2 Adjusted EPS $0.20, vs. FactSet Est of $0.12

Introduction

Company Name.
ODDITY Tech Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Oddity Tech Ltd. operates as a consumer tech company that builds and scales digital-first brands to disrupt beauty and wellness industries. The company serves consumers worldwide through its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. It owns IL MAKIAGE and SpoiledChild brands. The company was incorporated in 2013 and is headquartered in Tel Aviv, Israel with additional office in New York, New York.
Issue price:
--